Cart
sales@molnova.com
16,17-Epoxypregnenol
CAS No. 974-23-2
16,17-Epoxypregnenol( —— )
Catalog No. M19295 CAS No. 974-23-2
16,17-Epoxypregnenol
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | In Stock |
|
| 200MG | 47 | In Stock |
|
| 500MG | 77 | In Stock |
|
| 1G | 113 | In Stock |
|
Biological Information
-
Product Name16,17-Epoxypregnenol
-
NoteResearch use only, not for human use.
-
Brief Description16,17-Epoxypregnenol
-
Description16,17-Epoxypregnenol
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMAPK/ERK Signaling
-
Targetp38 MAPK
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number974-23-2
-
Formula Weight330.46
-
Molecular FormulaC21H30O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO1[C@@H]2C[C@H]3[C@@H]4CC=C5C[C@@H](O)CC[C@@]5([C@H]4CC[C@@]3([C@]12C(=O)C)C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Ro-3201195
Ro-3201195 is a novel orally available p38 MAPK inhibitor with high selectivity.
-
MW181 hydrochloride
MW181 (MW01-10-181SRM) is an isoform-selective, brain-permeable, and orally bioavailable small molecule inhibitor of p38α MAPK with Ki of 184 nM.
-
SKF-86002
SKF-86002 is a potent inhibitor of p38 MAPK with IC50 of 0.5-1 uM, inhibits LPS-induced IL-1 and TNF-α production in human monocyte with IC50 of 1 uM.
